Literature DB >> 28196842

Identifying the Intracellular Function of APOL1.

Leslie A Bruggeman1, John F O'Toole2, John R Sedor2,3.   

Abstract

Entities:  

Keywords:  cell death; chronic kidney disease; human genetics

Mesh：

Substances：

Year:  2017        PMID： 28196842      PMCID： PMC5373468          DOI： 10.1681/ASN.2016111262

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  18 in total

1.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

2.  APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes.

Authors:  Etty Kruzel-Davila; Revital Shemer; Ayala Ofir; Ira Bavli-Kertselli; Ilona Darlyuk-Saadon; Pazit Oren-Giladi; Walter G Wasser; Daniella Magen; Eid Zaknoun; Maya Schuldiner; Adi Salzberg; Daniel Kornitzer; Zvonimir Marelja; Matias Simons; Karl Skorecki
Journal:  J Am Soc Nephrol       Date:  2016-11-18       Impact factor: 10.121

3.  The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.

Authors:  B T Lee; V Kumar; T A Williams; R Abdi; A Bernhardy; C Dyer; S Conte; G Genovese; M D Ross; D J Friedman; R Gaston; E Milford; M R Pollak; A Chandraker
Journal:  Am J Transplant       Date:  2012-04-04       Impact factor: 8.086

4.  Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.

Authors:  Lijun Ma; Gregory S Shelness; James A Snipes; Mariana Murea; Peter A Antinozzi; Dongmei Cheng; Moin A Saleem; Simon C Satchell; Bernhard Banas; Peter W Mathieson; Matthias Kretzler; Ashok K Hemal; Lawrence L Rudel; Snezana Petrovic; Allison Weckerle; Martin R Pollak; Michael D Ross; John S Parks; Barry I Freedman
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

5.  APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.

Authors:  Leslie A Bruggeman; Zhenzhen Wu; Liping Luo; Sethu M Madhavan; Martha Konieczkowski; Paul E Drawz; David B Thomas; Laura Barisoni; John R Sedor; John F O'Toole
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

6.  Trypanosome Lytic Factor-1 Initiates Oxidation-stimulated Osmotic Lysis of Trypanosoma brucei brucei.

Authors:  Amy Styer Greene; Stephen L Hajduk
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

7.  Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort.

Authors:  Julia Kozlitina; Haihong Zhou; Patricia N Brown; Rory J Rohm; Yi Pan; Gulesi Ayanoglu; Xiaoyan Du; Eric Rimmer; Dermot F Reilly; Thomas P Roddy; Doris F Cully; Thomas F Vogt; Daniel Blom; Maarten Hoek
Journal:  J Am Soc Nephrol       Date:  2016-03-22       Impact factor: 10.121

Review 8.  APOL1 toxin, innate immunity, and kidney injury.

Authors:  Sophie Limou; Patrick D Dummer; George W Nelson; Jeffrey B Kopp; Cheryl A Winkler
Journal:  Kidney Int       Date:  2015-04-08       Impact factor: 10.612

9.  Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1.

Authors:  Gilles Vanwalleghem; Frédéric Fontaine; Laurence Lecordier; Patricia Tebabi; Kristoffer Klewe; Derek P Nolan; Yoshiki Yamaryo-Botté; Cyrille Botté; Anneke Kremer; Gabriela Schumann Burkard; Joachim Rassow; Isabel Roditi; David Pérez-Morga; Etienne Pays
Journal:  Nat Commun       Date:  2015-08-26       Impact factor: 14.919

10.  Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.

Authors:  Brendan Nichols; Prachi Jog; Jessica H Lee; Daniel Blackler; Michael Wilmot; Vivette D'Agati; Glen Markowitz; Jeffrey B Kopp; Seth L Alper; Martin R Pollak; David J Friedman
Journal:  Kidney Int       Date:  2014-08-06       Impact factor: 10.612
View more
  8 in total

1.  Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles.

Authors:  Jonathan Bruno; Nicola Pozzi; Jonathan Oliva; John C Edwards
Journal:  J Biol Chem       Date:  2017-09-15       Impact factor: 5.157

2.  UBD modifies APOL1-induced kidney disease risk.

Authors:  Jia-Yue Zhang; Minxian Wang; Lei Tian; Giulio Genovese; Paul Yan; James G Wilson; Ravi Thadhani; Amy K Mottl; Gerald B Appel; Alexander G Bick; Matthew G Sampson; Seth L Alper; David J Friedman; Martin R Pollak
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

3.  Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation.

Authors:  Dhruti P Chen; Ziad S Zaky; Jesse D Schold; Leal C Herlitz; Rasha El-Rifai; Paul E Drawz; Leslie A Bruggeman; Laura Barisoni; Susan L Hogan; Yichun Hu; John F O'Toole; Emilio D Poggio; John R Sedor
Journal:  Clin Transplant       Date:  2021-02-10       Impact factor: 2.863

4.  Kidney-disease-associated variants of Apolipoprotein L1 show gain of function in cation channel activity.

Authors:  Jonathan Bruno; John C Edwards
Journal:  J Biol Chem       Date:  2021-01-09       Impact factor: 5.157

5.  Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity.

Authors:  Etty Kruzel-Davila; Ira Bavli-Kertselli; Ayala Ofir; Amber M Cheatham; Revital Shemer; Eid Zaknoun; Sergiy Chornyy; Orly Tabachnikov; Shamara E Davis; Atanu K Khatua; Karl Skorecki; Waldemar Popik
Journal:  iScience       Date:  2021-12-31

Review 6.  The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.

Authors:  Parnaz Daneshpajouhnejad; Jeffrey B Kopp; Cheryl A Winkler; Avi Z Rosenberg
Journal:  Nat Rev Nephrol       Date:  2022-02-25       Impact factor: 42.439

7.  Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease.

Authors:  Richard Mayanja; Christopher Kintu; Oudou Diabate; Opeyemi Soremekun; Olugbenga Oluseun Oluwagbemi; Mamadou Wele; Robert Kalyesubula; Daudi Jjingo; Tinashe Chikowore; Segun Fatumo
Journal:  Genes (Basel)       Date:  2022-08-16       Impact factor: 4.141

8.  Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways.

Authors:  Archna Bajaj; Andrea Ihegword; Chengxiang Qiu; Aeron M Small; Wei-Qi Wei; Lisa Bastarache; QiPing Feng; Rachel L Kember; Marjorie Risman; Roy D Bloom; David L Birtwell; Heather Williams; Christian M Shaffer; Jinbo Chen; Regeneron Genetics Center; Joshua C Denny; Daniel J Rader; C Michael Stein; Scott M Damrauer; Katalin Susztak
Journal:  Kidney Int       Date:  2020-02-17       Impact factor: 10.612
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.